Gøril Berntzen, PhD, Group Lead Discovery
Gøril is an experienced molecular immunologist with expertise in drug and target discovery by use of phage display technologies in several disease areas including autoimmunity and oncology. She received her PhD in Molecular Immunology from the University of Oslo in 2006 and has since gained experience working in academia and for immunotherapy companies, including Affitech. Gøril joined Nextera in 2013 and is leading the Discovery Group on phage display selection and screening campaigns in immunotherapy discovery programs.
Sebastian Berge-Seidl, PhD, Group Lead Molecular Biology
Sebastian has over 15 years’ experience in the field of molecular biology across various scientific disciplines, including cancer biology, cardiovascular disease, and immunology, with additional experience in project management. He received his PhD in Cancer Biology from the University of Oslo in 2013. Sebastian joined Nextera in 2016 and is leading the Molecular Biology Group focusing on compound design and development of new technologies.